Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Tesla Eyes $2.9 Billion in Chinese Solar Equipment to Power 100 GW U.S. Manufacturing Push
Asian Currencies Slide as Oil Prices Surge Amid U.S.-Israel-Iran Conflict
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review
U.S.-Iran War Escalates: Marines Deploy, Strait of Hormuz Closure Drives Global Oil Crisis
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
Gold Prices Drop Amid Inflation Fears and U.S.-Iran Escalation
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
Iran-Israel War Escalates: Long-Range Missiles, Nuclear Site Strikes, and Global Energy Crisis
United Airlines Cuts Flights 5% Amid Soaring Fuel Costs From Iran War
EA's $15B Debt Offering Draws $25B in Investor Demand Amid Credit Market Turmoil
Volkswagen CEO Urges Germany to Adopt China's Industrial Discipline Amid Major Restructuring
U.S. Stock Futures Slide as Iran Conflict and Inflation Fears Rattle Wall Street
US-Iran War: Trump Eyes Military Exit as Markets React to Potential De-escalation
Trump Issues 48-Hour Ultimatum to Iran Over Strait of Hormuz, Threatens Power Grid Strikes
Palantir's Maven AI Earns Pentagon "Program of Record" Status, Reshaping Military AI Strategy
Sinopec Posts 36.8% Net Profit Drop in 2025 Amid Weak Petrochemical Margins and Energy Transition Pressures
Gold Prices Extend Losing Streak, On Track for Worst Weekly Loss Since 1983 



